RADIOLABELING OF POLYMER MICROSPHERES FOR SCINTIGRAPHIC INVESTIGATIONS BY NEUTRON-ACTIVATION .4. A PHARMACOSCINTIGRAPHY STUDY OF COLON-TARGETED EUDRAGIT RS-SULFAPYRIDINE MICROSPHERES IN HUMAN VOLUNTEERS
Pj. Watts et al., RADIOLABELING OF POLYMER MICROSPHERES FOR SCINTIGRAPHIC INVESTIGATIONS BY NEUTRON-ACTIVATION .4. A PHARMACOSCINTIGRAPHY STUDY OF COLON-TARGETED EUDRAGIT RS-SULFAPYRIDINE MICROSPHERES IN HUMAN VOLUNTEERS, International journal of pharmaceutics, 102(1-3), 1994, pp. 101-108
Dosage forms containing sulphapyridine have been administered to a gro
up of five human subjects in a two-part combined pharmacokinetic and g
amma scintigraphic study. In one portion of the study, subjects were a
dministered enteric-coated capsules containing sulphapyridine powder a
nd Tc-99m-labelled ion-exchange resin. In the second portion of the st
udy, the subjects were administered enteric-coated capsules containing
Sm-153-labelled sustained-release sulphapyridine-Eudragit RS microsph
eres. In both cases, the enteric-coated capsules were designed to deli
ver their contents into the caecum or ascending colon. Following capsu
le disintegration, the residence time of 50% of the radiolabelled micr
ospheres in the ascending colon was 8.4+/-2.0 h (n = 5), which did not
differ significantly from the residence time of 50% of the radiolabel
led ion-exchange resin (7.2+/-1.9 h, n = 5). Pharmacokinetic analysis
indicated a prolongation of drug release from the microsphere formulat
ion. The bioavailability of sulphapyridine from the microspheres relat
ive to the non-encapsulated drug powder was 41.3+/-12.7% (n = 4). The
reason for the reduction in drug absorption from the microsphere formu
lation was unclear although several theories are proposed.